Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

Headlines for Spectrum Pharmaceuticals, Inc.

Omeros Corporation plans earnings filing Thursday; OMER, ACET, SPPI
Learning Markets - Nov 18, 2009
Traders watch earnings announcements keenly, as changes in a company's financials can be a good indication whether a company is on the right track, or headed the wrong way. Omeros Corporation ...
Spectrum Pharmaceuticals Added to NASDAQ Biotechnology Index
Earthtimes - Nov 16, 2009
IRVINE, Calif. - (Business Wire) Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has been ...
Spectrum Pharmaceuticals Joins NASDAQ Biotechnology Index - Trading Markets
NIPPON KAYAKU BUYS ASIA RIGHTS TO BLADDER CANCER DRUG
Trading Markets - Nov 16, 2009
TOKYO, Nov 16, 2009 (AsiaPulse via COMTEX) -- SPPI -- Nippon Kayaku Co. (TSE:4272) has gained development and marketing rights in Asia except South Korea to a bladder-cancer agent from US company ...
NEWS OF THE WEEK
Orange County Business Journal - Nov 15, 2009
Costa Mesa's Emulex Corp. filed a lawsuit against spurned suitor Broadcom Corp. alleging anti-competitive practices at the Irvine chipmaker. The lawsuit comes two months after Broadcom filed a ...
Spectrum Pharmaceuticals and Nippon Kayaku Collaborate to Develop Apaziquone in Asia
Trading Markets - Nov 14, 2009
Nov 13, 2009 (Close-Up Media via COMTEX) -- SPPI -- Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, and Nippon Kayaku announced an ...